Boltwood Capital Management Bristol Myers Squibb CO Transaction History

Boltwood Capital Management

$336 Million
Q3 2024

A detailed history of Boltwood Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boltwood Capital Management holds 3,945 shares of BMY stock, worth $214,292. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,945

Holding current value

$214,292

% of portfolio

0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	BUY	$39.66 - $51.75 $156,458 - $204,153	3,945 New	3,945 $204,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $1,447 - $1,618	-25 Reduced 0.71%	3,513 $203,000
Q2 2023 Jul 06, 2023	BUY	$63.71 - $70.74 $3,185 - $3,536	50 Added 1.43%	3,538 $226,000
Q1 2023 Apr 03, 2023	BUY	$65.71 - $74.53 $19,712 - $22,359	300 Added 9.41%	3,488 $241,000
Q4 2022 Jan 06, 2023	SELL	$68.48 - $81.09 $2,739 - $3,243	-40 Reduced 1.24%	3,188 $0
Q3 2022 Oct 04, 2022	SELL	$0.13 - $76.84 $7 - $4,610	-60 Reduced 1.82%	3,228 $229,000
Q2 2022 Jul 07, 2022	BUY	$72.62 - $79.98 $14,378 - $15,836	198 Added 6.41%	3,288 $253,000
Q1 2022 Apr 20, 2022	SELL	$61.48 - $73.72 $16,599 - $19,904	-270 Reduced 8.04%	3,090 $226,000
Q4 2021 Jan 10, 2022	SELL	$53.63 - $62.52 $21,452 - $25,008	-400 Reduced 10.64%	3,360 $209,000
Q3 2021 Oct 08, 2021	SELL	$59.17 - $69.31 $37,040 - $43,388	-626 Reduced 14.27%	3,760 $222,000
Q2 2021 Jul 06, 2021	SELL	$61.91 - $67.42 $12,382 - $13,484	-200 Reduced 4.36%	4,386 $293,000
Q1 2021 Apr 05, 2021	SELL	$59.34 - $66.74 $12,758 - $14,349	-215 Reduced 4.48%	4,586 $290,000
Q4 2020 Jan 04, 2021	SELL	$57.74 - $65.43 $39,263 - $44,492	-680 Reduced 12.41%	4,801 $298,000
Q2 2020 Jul 02, 2020	SELL	$54.82 - $64.09 $77,844 - $91,007	-1,420 Reduced 20.58%	5,481 $322,000
Q1 2020 Apr 07, 2020	SELL	$46.4 - $67.43 $102,080 - $148,346	-2,200 Reduced 24.17%	6,901 $385,000
Q4 2019 Jan 07, 2020	SELL	$49.21 - $64.19 $661,136 - $862,392	-13,435 Reduced 59.62%	9,101 $584,000
Q3 2019 Oct 02, 2019	BUY	$42.77 - $50.71 $38,920 - $46,146	910 Added 4.21%	22,536 $1.14 Million
Q2 2019 Jul 01, 2019	BUY	$44.62 - $49.34 $17,848 - $19,736	400 Added 1.88%	21,626 $981,000
Q1 2019 Apr 02, 2019	BUY	$45.12 - $53.8 $93,127 - $111,043	2,064 Added 10.77%	21,226 $1.01 Million
Q4 2018 Jan 07, 2019	SELL	$48.76 - $63.23 $12,823 - $16,629	-263 Reduced 1.35%	19,162 $996,000
Q3 2018 Oct 10, 2018	BUY	$55.19 - $62.25 $33,886 - $38,221	614 Added 3.26%	19,425 $1.21 Million
Q2 2018 Jul 06, 2018	BUY	$50.53 - $62.98 $10,863 - $13,540	215 Added 1.16%	18,811 $1.04 Million
Q1 2018 Apr 05, 2018	SELL	$59.92 - $68.98 $11,025 - $12,692	-184 Reduced 0.98%	18,596 $1.18 Million
Q4 2017 Jan 10, 2018	BUY	$59.94 - $65.35 $36,563 - $39,863	610 Added 3.36%	18,780 $1.15 Million
Q3 2017 Oct 10, 2017	BUY	$55.23 - $63.74 $1 Million - $1.16 Million	18,170	18,170 $1.16 Million

Others Institutions Holding BMY

# of Institutions

2,449

Shares Held

1.51B

Call Options Held

29.7M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boltwood Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Boltwood Capital Management with notifications on news.

Account

Boltwood Capital Management Bristol Myers Squibb CO Transaction History